Implant Safety and Monitoring: What the FDA Actually Recommends

Breast implants are among the most studied medical devices in existence, and yet the safety conversation around them is dominated by extremes: practices that wave concerns away, and corners of the internet that treat every implant as a slow-motion emergency. The truth sits in the documented middle. This explainer lays out what the FDA currently requires, what the known risks actually are, and what a responsible monitoring plan looks like for a Los Angeles patient.

The black box warning, in context

Since 2021, breast implants in the United States carry a boxed warning, the FDA's most prominent labeling requirement. Surgeons must review a patient decision checklist with you before surgery. The warning exists because implants are not lifetime devices, because certain rare risks are real, and because the FDA concluded patients were not consistently being told either fact. A practice that walks you through the checklist carefully is not being alarmist. It is being compliant, and it is a good sign about everything else the practice does.

Rupture screening: the actual schedule

For silicone gel implants, current FDA guidance recommends imaging at five to six years after placement, then every two to three years after that. Ultrasound is the usual first-line tool, with MRI when ultrasound is inconclusive. Saline implants need no imaging, because a rupture announces itself through visible deflation. These scans are usually not covered by insurance for cosmetic patients and typically run a few hundred dollars each in Los Angeles, a recurring cost that belongs in your long-term budget from the start.

BIA-ALCL: what the numbers say

Breast implant-associated anaplastic large cell lymphoma is a rare cancer of the immune system found in the scar capsule around implants, overwhelmingly associated with textured devices. Published risk estimates for patients with the recalled high-texture implants range from roughly one in a few hundred to one in several thousand, while the risk with the smooth implants used in nearly all current US augmentations is dramatically lower, with only a handful of reported smooth-only cases worldwide. The disease is highly treatable when caught early. The practical takeaway: know your device, keep your implant card, and report new swelling around an implant, especially years later, to your surgeon promptly.

Breast implant illness: the honest state of the evidence

Some patients report fatigue, joint pain, brain fog, and other systemic symptoms they attribute to their implants, a constellation now commonly called breast implant illness. It is not currently a formal diagnosis, and studies have not established a causal mechanism. What the data does show is that a meaningful subset of patients who choose explant surgery report symptom improvement afterward. The FDA now requires this topic to appear in patient labeling. A trustworthy surgeon will neither diagnose you with it nor dismiss it, and will discuss explant as a legitimate option if symptoms and your own judgment point that way.

Capsular contracture and ordinary maintenance

The most common implant complication is not exotic. Capsular contracture, a tightening of the scar tissue around the implant, affects a meaningful minority of patients over a decade and is the leading reason for revision surgery. Early signs are firmness and a change in implant position. Routine self-checks, annual exams, and the habits covered in our guide to living with implants long term catch most problems while they are still simple to address.

What a responsible plan looks like

Distilled to a checklist: keep your implant card with manufacturer, model, and serial numbers. Calendar your first ultrasound at year five if you chose silicone. See your surgeon or a breast specialist annually. Report new swelling, firmness, pain, or shape change at any point, even fifteen years out. And before surgery, confirm your surgeon registers devices with the national breast implant registry, which strengthens the safety data every future patient relies on.

The bottom line

The modern safety picture is neither the horror story nor the brochure. Smooth implants placed by a board-certified surgeon, monitored on the FDA schedule, carry small and mostly manageable risks that are well documented. The patients who do best are the ones who treat monitoring as part of the deal they accepted, not an optional extra.